With NSE Sidelined, Shares of India Exchanges Are Floundering
(Bloomberg) -- India's dominant stock venue is unable to list its shares due to a regulatory probe. For the last six months, investors probably wished the country's other exchanges never went public, either.
Multi Commodity Exchange of India Ltd. fell the most among all global exchanges in the past six months, declining 29 percent. BSE Ltd., which trades stocks and currency derivatives, dropped 17 percent. Both are struggling to increase volume and expand due to strict regulatory oversight, according to Ashish Chopra, analyst at Motilal Oswal Securities Ltd.
BSE hosts less than 20 percent of stock market trading and 5 percent of derivatives in India, with NSE controlling the rest. Volume traded in Indian commodity derivatives exchanges dropped by half in the year ended March 2018 from four years ago, according to data from the regulator. “Volume growth may still happen, but revenue growth may not be that great,” Ashishkumar Chauhan, chief executive officer at BSE, said in an interview. “We don't do business like a business, we are more focused in compliance as frontline regulators. And if the business happens, that's OK.”
The operator of India's top bourse shelved plans to list in 2017 because of an investigation into whether the exchange gave high-frequency traders unfair access to its systems. NSE's former CEO Chitra Ramkrishna quit weeks before it filed an IPO draft prospectus, while millions of dollars of revenue has been temporarily confiscated by the regulator. Even though NSE said it is looking to sell shares in an IPO by March 2019, it's not clear it will make the deadline.
To contact the reporter on this story: Santanu Chakraborty in Mumbai at schakrabor11@bloomberg.net.
To contact the editors responsible for this story: Divya Balji at dbalji1@bloomberg.net, Chris Nagi
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.